Cathelicidin Host Defence Peptide Augments Clearance of Pulmonary Pseudomonas aeruginosa Infection by Its Influence on Neutrophil Function In Vivo
出版年份 2014 全文链接
标题
Cathelicidin Host Defence Peptide Augments Clearance of Pulmonary Pseudomonas aeruginosa Infection by Its Influence on Neutrophil Function In Vivo
作者
关键词
-
出版物
PLoS One
Volume 9, Issue 6, Pages e99029
出版商
Public Library of Science (PLoS)
发表日期
2014-06-03
DOI
10.1371/journal.pone.0099029
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Neutrophil-Derived Cathelicidin Promotes Adhesion of Classical Monocytes
- (2013) Sarawuth Wantha et al. CIRCULATION RESEARCH
- Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa
- (2013) D. M. Hermes et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Ability of Innate Defence Regulator Peptides IDR-1002, IDR-HH2 and IDR-1018 to Protect against Mycobacterium tuberculosis Infections in Animal Models
- (2013) Bruno Rivas-Santiago et al. PLoS One
- Serum cathelicidin level is associated with viral etiology and severity of bronchiolitis
- (2012) Jonathan M. Mansbach et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cathelicidin-Related Antimicrobial Peptide Is Required for Effective Lung Mucosal Immunity in Gram-Negative Bacterial Pneumonia
- (2012) M. A. Kovach et al. JOURNAL OF IMMUNOLOGY
- ß-Defensins: Multifunctional Modulators of Infection, Inflammation and More?
- (2012) Fiona Semple et al. Journal of Innate Immunity
- Induction of the human cathelicidin LL-37 as a novel treatment against bacterial infections
- (2012) Anne M. van der Does et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients
- (2011) A. Pompilio et al. PEPTIDES
- Phenylbutyrate Counteracts Shigella Mediated Downregulation of Cathelicidin in Rabbit Lung and Intestinal Epithelia: A Potential Therapeutic Strategy
- (2011) Protim Sarker et al. PLoS One
- Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37
- (2011) Peter G. Barlow et al. PLoS One
- The Human Cathelicidin LL-37 Preferentially Promotes Apoptosis of Infected Airway Epithelium
- (2010) Peter G. Barlow et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils
- (2010) Sadek M. Alalwani et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Flagellin Stimulates Protective Lung Mucosal Immunity: Role of Cathelicidin-Related Antimicrobial Peptide
- (2010) F.-s. Yu et al. JOURNAL OF IMMUNOLOGY
- LL-37 Directs Macrophage Differentiation toward Macrophages with a Proinflammatory Signature
- (2010) A. M. van der Does et al. JOURNAL OF IMMUNOLOGY
- Phenylbutyrate Induces Antimicrobial Peptide Expression
- (2009) J. Steinmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils
- (2009) Zhifang Zhang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages
- (2009) Hsin-Ni Li et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The Human Host Defense Peptide LL-37 Induces Apoptosis in a Calpain- and Apoptosis-Inducing Factor-Dependent Manner Involving Bax Activity
- (2009) J. S. Mader et al. MOLECULAR CANCER RESEARCH
- Topical versus Systemic Antimicrobial Therapy for Treating Mildly Infected Diabetic Foot Ulcers: A Randomized, Controlled, Double‐Blinded, Multicenter Trial of Pexiganan Cream
- (2008) Benjamin A. Lipsky et al. CLINICAL INFECTIOUS DISEASES
- Antimicrobial peptides and the skin immune defense system
- (2008) Jürgen Schauber et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More